J o u r n a l o f t h e A m e r i c a n P h a r m a c i s t s A s s o c i a t i o n
C linical pharmacy services in primary care clinics have been evolving for two generations. Pharmacist provision of distribution and clinical services in various primary care clinic settings (e.g., private practice, 1 Indian Health Service, 2 residency training programs 3 ) has been described since the mid-1970s. Recently, a new primary care model, the patient-centered medical home (PCMH), has emerged, presenting pharmacists with an opportunity to be part of a comprehensive physician-directed health care team. PCMH provides structured and coordinated care around the specific needs of each patient with sustained relationships between patients and their PCMH team practitioners. 4 
Objective
We describe a pharmacy's journey toward incorporation into PCMH.
Clinic history
Valley View Clinical Pharmacists (VVCP) in Monroe, WA, was established in 1981. The pharmacist and physicians had a previous positive working relationship in a family medicine residency program. The family practice physicians learned the value of clinical pharmacy services from their residency experience and decided to incorporate them into their new practices. The medical and pharmacy practices were private-
At a Glance
Synopsis: Clinical pharmacy services at Valley View Clinical Pharmacists (VVCP) in Monroe, WA, have been evolving for two generations and are now integrated into a patient-centered medical home (PCMH). Pharmacists at VVCP implemented collaborative practice agreements with clinic physicians as a result of changes in Washington's pharmacy practice act in 1981, and clinical pharmacy services have expanded over time. Because of the history of collaborative relationship, pharmacists were included in a PCMH pilot through an internally funded grant. Pharmacist activities included value-added refill authorization services, coordinated patient visits with the PCMH pharmacist and physicians, medication therapy management, diabetes and anticoagulation services, hospital discharge medication reconciliation, and participation in the shared medical appointment.
Analysis Pharmacists at VVCP were among the first to implement collaborative practice agreements with clinic physicians as a result of changes in the state's pharmacy practice act in 1981. 5 Agreements between the pharmacists and physicians included therapeutic substitution, initiation of new drug therapy, and limited refill authorizations for patients shared by the clinic and pharmacy. With growth of the pharmacy practice, a community pharmacy residency program commenced in 1990.
By April 2000, both the clinic and pharmacy had been purchased by Providence Health & Services (PH&S) and remained intact as traditional fee-for-service entities. The PH&S acquisition resulted in new collaborative efforts, as both practices now had common ownership. From the initial five family physicians in 1981, the clinic has grown to eight family physicians with two midlevel practitioners, two internists, and two pediatricians. The pharmacy has grown to 12 full-time equivalent employees, with 3 pharmacists and 2 pharmacy residents. The pharmacy dispenses approximately 90,000 prescriptions per year in addition to other traditional services. Clinical services have evolved over time. A list of traditional and clinical services with implementation dates is shown in Table 1 . Evaluation of clinical services has been the focus of pharmacy resident projects.
Reimbursement challenges
Payment for clinical pharmacy services has been the primary obstacle for service expansion. Various payment methods have been trialed during the previous 30 years by the clinic pharmacy ( Table 2) . During the early years of collaboration, the medical group paid the pharmacists a monthly fee for consultative services. With the acquisition of the clinic and pharmacy by PH&S, increased emphasis has been placed on clinical pharmacy services to improve clinic efficiencies, improve patient outcomes, and decrease health care costs. Clinical services have been subsidized with net revenue from dispensing. The pharmacy has a relatively high capture rate of clinic prescriptions compared with other PH&S outpatient pharmacies without clinical services. Physicians supervise and bill for anticoagulation care provided by pharmacists using the level 1 or 99211 code for "incident to" visits. VVCP has been unsuccessful in obtaining payment from regional commercial third-party payers for non-Medicare Part D services for medication therapy management (MTM). Therefore, pharmacists' focus shifted to increasing physician productivity.
Like other primary care physician practices, Providence Medical Group (PMG) has struggled with low reimbursement, physician recruitment and retention, and poor access to physicians by patients. PMG anticipates being affected by the current national primary care physician shortage. Health care reform is expected to exacerbate the shortage as more patients enter the health care system.
SPECIAL FEATURE PCMh PhARMACiST

PCMH
PCMH has been advocated as a way to improve patient care through a robust redesigned primary care model. 6 PMG has been investigating the PCMH model to proactively address its primary care challenges.
Participation in PCMH by the PMG Monroe clinic began in July 2009. Because of the history of collaborative relationship, pharmacists were included in a PCMH pilot through an internally funded grant. The pilot was limited to two internal medicine physicians and had administrative support and a physician champion. (Table 3) . Clinical pharmacy services were designed to support each element of PCMH.
Pharmacist activities
One of the early identified goals of the PCMH team was to "leverage physician time" or improve physician productivity. Physician activities that could be performed by another team member were reviewed. For example, value-added refill authorization services for noncontrolled substances became one of the PCMH pharmacist's responsibilities. While evaluating refill requests, pharmacists identify and recommend appropriate laboratory tests and initiate referrals in compliance with collaborative practice agreements. A 5-week study of the refill service showed that it saved each physician an average of 17 hours per month. 9 A coordinated patient visit with the pharmacist and physician was identified as another method to improve physician use. By having pharmacists perform a comprehensive medication review for selected patients, physician time savings could be achieved. Each morning before clinic, a pharmacist meets with the physicians to review the schedule and identify patients for pharmacist involvement. Patients on multiple 
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PCMh PhARMACiST SPECIAL FEATURE chronic medications or who have not met treatment goals are requested to arrive early with all of their medications for a previsit medication review by the pharmacist. Medication issues are identified and resolutions recommended to the physician before the "warm hand off" of the patient to the physician. When a same-day previsit interview is insufficient, the physician refers the patient for a separate pharmacist MTM visit. Coordinated care is a core feature of PCMH. With medication records often fragmented among mail service pharmacies, specialty pharmacies, and multiple community pharmacies, the PCMH pharmacist is optimally situated to coordinate and integrate comprehensive medication management. 10 Through use of the electronic medical record (EMR), the pharmacist can review clinic notes, specialist notes, emergency department visits, and hospital discharge summaries to update the medication list. Therapeutic issues can be resolved efficiently with direct communication with the primary care provider, discussion with the patient, and documentation in the EMR.
Therapeutic monitoring and extended patient education is another pharmacist activity. Patients with diabetes are routinely referred to the pharmacist for medication injection instruction, glucose monitor teaching, and supplemental education. In addition, patients with diabetes requiring additional support are routinely referred to the pharmacist for monitoring and medication adjustments according to collaborative practice agreements. Similarly, anticoagulation services also have been incorporated into the PCMH pharmacist's responsibilities.
PH&S has placed a high priority on minimizing 30-day hospital readmissions because of potential cost savings and improved patient care. 11 Patients discharged from the hospital with a diagnosis of diabetes, congestive heart failure, or pneumonia or who discharged with more than eight medications are contacted by the pharmacist within 72 hours of discharge for medication reconciliation.
Another activity for the PCMH pharmacist is participation in the shared medical appointment (SMA). A small population of patients with diabetes (n = 8-15) is invited to a 90-minute group appointment. Pharmacist activities include previsit medication review with each patient, evaluating glucose meter readings, making recommendations to the physician, EMR documentation, and serving as a resource at the SMA. Initial patient response has been favorable, and other patient populations are being identified for the SMA format.
Payment reform
Payment reform is the last core feature of PCMH, as financial success is key to sustainability. Although integrated health plan-health care delivery systems can finance PCMH through decreased health care costs, 12 other health care systems need to look elsewhere for financial support. Potential funding sources include improved clinic productivity, pay for performance, and increased third-party reimbursement through SPECIAL FEATURE PCMh PhARMACiST capitated or globally budgeted PCMHs. 13 As reimbursement changes to reward clinical outcomes, pharmacist activities in achieving quality metrics will be important in supporting the PCMH pharmacist. While these reimbursement models evolve, up-front funding may be required to assemble the PCMH infrastructure. 14 Increased clinical opportunities exist for pharmacists within the primary care PCMH. A team-based approach, led by a physician, offers opportunities for pharmacists as part of a group versus practicing as an independent provider. Because pharmacists lack provider status by Medicare and other payers, pharmacists have had limited success in obtaining reimbursement for clinical services other than for Medicare Part D MTM. Traditional fee-for-service payments that currently exclude pharmacists would be replaced by a different payment method that rewards team care. PMG is currently exploring such reimbursement models with regional payers. Payment reform could be the most important feature of supporting pharmacists within PCMH.
The future
The pharmacist's clinical practice in PCMH continues to evolve. Recently, a part-time nurse case manager has been added to the team. Funding currently is being sought to expand PCMH to the entire clinic while new opportunities for pharmacists are explored.
VVCP pharmacy residents are trained in the PCMH model. PCMH has been the focus of resident projects for the previous few years. Residents participate in WPCMHC meetings, weekly team meetings, and all aspects of care. Residents who have completed the VVCP residency program have obtained positions with other organizations that were implementing medical homes. Now two generations old, clinical pharmacy services at VVCP are woven into the PCMH fabric. A new generation of clinical pharmacists will be challenged and rewarded in this evolving health care model. A list of medical home websites and resources is provided (Appendix 1 in the electronic version of this article, available online at www.japha.org) to help pharmacists gain familiarity with these important developments for health care.
